In addition, blockage of EGF in vivo can remarkably attenuate the bone resportion and osteoclast formation in bone metastasis of CRC, demonstrating that EGF is an important regulator in promoting bone destruction in CRC. This evidence concerns the gene EGF and colorectal carcinoma.